Naphazoline EP Impurity D (HCl Salt)
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

6028-15-5Naphazoline EP Impurity D (HCl Salt)

● Auf Lager

Katalog-Nr.::VE0021522
CAS-Nr.::6028-15-5
Summenformel::C14H15ClN2
Molare Masse::246.74 g/mol

Zusätzliche Informationen zu CAS 6028-15-5

Parent drug

Naphazoline

IUPAC-Name

2-(Naphthalen-2-ylmethyl)-4, 5-dihydro-1H-imidazole Hydrochloride (beta-Naphazoline Hydrochloride)

Pharmakopöe-Synonyme

beta-Naphazoline Hydrochloride

Other Synonyms

N/A

SMILES

C1(C=CC=C2)=C2C=CC(CC3=NCCN3)=C1

InChI

InChI=1S/C14H14N2.ClH/c1-2-4-13-9-11(5-6-12(13)3-1)10-14-15-7-8-16-14;/h1-6, 9H, 7-8, 10H2, (H, 15, 16);1H

Beschreibung

Naphazoline EP Impurity D (HCl Salt) | also known in pharmacopoeias as beta-Naphazoline Hydrochloride | is a highly characterized reference material. It fully complies with stringent regulatory standards | including those set by USP | EMA | JP | and BP. This product is essential for use in Abbreviated New Drug Applications (ANDA) | New Drug Applications (NDA) | and the commercial production of Naphazoline. Moreover | it comes with a detailed Structure Elucidation Report (SER) | ensuring its accuracy and reliability for a wide range of analytical applications.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url